Related Experiment Video

Updated: Aug 20, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Cyclin G2 dysregulation in human oral cancer

Yong Kim1, Satoru Shintani, Yohko Kohno

  • 1School of Dentistry and Dental Research Institute, University of California at Los Angeles, Los Angeles, California, USA.

Cancer Research
|December 18, 2004
PubMed

Insights

Human cyclin G2 (hCG2) is down-regulated in oral cancer, inhibiting proliferation and cell cycle progression. Loss of hCG2 promotes oral epithelial cell growth, suggesting its role in oral cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Human cyclin G2 (hCG2) was previously found to be significantly downregulated in oral cancer epithelia.
  • hCG2 protein was detected in normal oral keratinocytes but absent in malignant cell lines.

Purpose of the Study:

  • To investigate the role of hCG2 in oral cancer development and progression.
  • To determine the functional impact of hCG2 on oral epithelial cell proliferation and cell cycle.

Main Methods:

  • Expression microarray and Western blot analysis to assess hCG2 levels.
  • Immunohistochemistry to evaluate hCG2 expression in oral tissues.
  • In vitro studies involving ectopic hCG2 restoration and gene silencing using short interference RNA (siRNA).

Main Results:

  • hCG2 was highly expressed in normal oral mucosa and dysplastic epithelia but significantly reduced in oral cancers.
  • Restoring hCG2 expression in oral cancer cells inhibited proliferation and colony formation, causing G1 cell cycle arrest.
  • Downregulating hCG2 in normal oral keratinocytes enhanced cell growth and altered cell cycle distribution.

Conclusions:

  • Dysregulation of hCG2 is implicated in oral epithelial transformation and the early stages of oral cancer.
  • hCG2 functions as a tumor suppressor by negatively regulating cell cycle progression.
  • hCG2 may serve as a potential biomarker or therapeutic target for oral cancer.

More Related Videos

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids10:43

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Published on: December 23, 2022

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...